DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,226,000 | -6.9% | 32,447 | +7.8% | 0.58% | +4.9% |
| Q1 2022 | $8,831,000 | -11.0% | 30,106 | -0.2% | 0.55% | -7.8% |
| Q4 2021 | $9,923,000 | +6.2% | 30,160 | -1.8% | 0.60% | -5.1% |
| Q3 2021 | $9,346,000 | +10.8% | 30,699 | -2.3% | 0.63% | +13.9% |
| Q2 2021 | $8,435,000 | +20.1% | 31,433 | +0.8% | 0.55% | +10.1% |
| Q1 2021 | $7,022,000 | +1.1% | 31,197 | -0.2% | 0.50% | -3.6% |
| Q4 2020 | $6,944,000 | +1.5% | 31,261 | -1.6% | 0.52% | -11.1% |
| Q3 2020 | $6,844,000 | +22.7% | 31,782 | +0.7% | 0.59% | +12.9% |
| Q2 2020 | $5,579,000 | +40.7% | 31,559 | +10.1% | 0.52% | +8.6% |
| Q1 2020 | $3,966,000 | +4.6% | 28,655 | +21.5% | 0.48% | +22.2% |
| Q4 2019 | $3,792,000 | +16.0% | 23,584 | +4.2% | 0.39% | -0.8% |
| Q3 2019 | $3,270,000 | +16.1% | 22,638 | +14.8% | 0.40% | +14.8% |
| Q2 2019 | $2,817,000 | +12.7% | 19,712 | +4.1% | 0.34% | +7.2% |
| Q1 2019 | $2,500,000 | +24.5% | 18,940 | -2.8% | 0.32% | 0.0% |
| Q4 2018 | $2,008,000 | +11.2% | 19,477 | +17.3% | 0.32% | +32.1% |
| Q3 2018 | $1,805,000 | +16.2% | 16,609 | +5.5% | 0.24% | -7.6% |
| Q2 2018 | $1,553,000 | +10.5% | 15,742 | +9.7% | 0.26% | +1.2% |
| Q1 2018 | $1,405,000 | +4.9% | 14,355 | +7.8% | 0.26% | +8.8% |
| Q4 2017 | $1,339,000 | +22.5% | 13,312 | +4.5% | 0.24% | +11.2% |
| Q3 2017 | $1,093,000 | +1.6% | 12,737 | -0.1% | 0.22% | -15.0% |
| Q2 2017 | $1,076,000 | +2.5% | 12,747 | +3.8% | 0.25% | -9.6% |
| Q1 2017 | $1,050,000 | +36.0% | 12,278 | +23.9% | 0.28% | +20.7% |
| Q4 2016 | $772,000 | +5.3% | 9,913 | +6.1% | 0.23% | -4.9% |
| Q3 2016 | $733,000 | -28.5% | 9,345 | -7.9% | 0.24% | -32.0% |
| Q2 2016 | $1,025,000 | +7.6% | 10,149 | +1.0% | 0.36% | +1.4% |
| Q1 2016 | $953,000 | -1.8% | 10,046 | -3.8% | 0.35% | +6.9% |
| Q4 2015 | $970,000 | +96.0% | 10,440 | +79.7% | 0.33% | +59.1% |
| Q3 2015 | $495,000 | -16.4% | 5,809 | -16.5% | 0.21% | -8.4% |
| Q2 2015 | $592,000 | +27.6% | 6,957 | +27.3% | 0.23% | +15.2% |
| Q1 2015 | $464,000 | -0.4% | 5,464 | +0.4% | 0.20% | -4.4% |
| Q4 2014 | $466,000 | +11.5% | 5,440 | -1.1% | 0.21% | -13.8% |
| Q3 2014 | $418,000 | +1.5% | 5,503 | +5.1% | 0.24% | +17.7% |
| Q2 2014 | $412,000 | +5.1% | 5,235 | +0.2% | 0.20% | -5.6% |
| Q1 2014 | $392,000 | +0.5% | 5,224 | +3.3% | 0.22% | -4.0% |
| Q4 2013 | $390,000 | +21.9% | 5,057 | +9.5% | 0.22% | -2.2% |
| Q3 2013 | $320,000 | +24.0% | 4,617 | +13.3% | 0.23% | +8.5% |
| Q2 2013 | $258,000 | – | 4,074 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |